InvestmentJun 18, 2026, 09:26 AM
Valion Bio Issues $250K in Preferred Shares & Warrants to 3i
AI Summary
Valion Bio, Inc. (formerly Tivic Health Systems, Inc.) issued 250 Series B Non-Voting Convertible Preferred Shares and warrants to purchase 156,026 common shares to 3i, LP, for an aggregate purchase price of $250,000. This transaction, completed on June 17, 2026, is part of a previously announced Securities Purchase Agreement from April 29, 2025, which was later assigned to 3i. The securities were issued under an exemption from registration.
Key Highlights
- Valion Bio issued 250 Series B Preferred Shares to 3i, LP.
- The Series B Preferred Shares were issued at $1,000 per share.
- Warrants to purchase 156,026 common shares were also issued to 3i.
- The warrant exercise price is $0.616280 per common share.
- The aggregate purchase price for these securities was $250,000.
- This transaction is part of a larger agreement for up to $8,400,000 in securities.
- Securities were issued under an exemption from registration.
Price Impact
More from TIVC